Pilates for the Prevention of Musculoskeletal Complaints During Pregnancy

Sponsor
Universidade Cidade de Sao Paulo (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05904925
Collaborator
(none)
20
2
30

Study Details

Study Description

Brief Summary

The goal of this pilot randomized controlled trial with economic evaluation is to evaluate the viability of Pilates in the prevention of musculoskeletal complaints, throughout the entire gestational period, in pregnant women. The main question it aims to answer is if it is feasible to perform exercises during the entire gestational period to prevent musculoskeletal disorders. Participants will be assessed primarily for acceptability, suitability, feasibility, and fidelity, and secondarily for the occurrence of musculoskeletal complaint and the number of days from randomization on which this musculoskeletal complaint occurred, type of delivery and costs. Then, participants will be randomized into two groups: the usual care group, which will receive an educational booklet with information about the usual care during pregnancy, and the Pilates group, which will receive the same educational booklet and will participate in a specific Pilates exercise program for the gestational period, twice a week, throughout the pregnancy.

Condition or Disease Intervention/Treatment Phase
  • Other: Pilates exercises
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Pilates Exercises for the Prevention of Musculoskeletal Complaints During Pregnancy: a Protocol of a Pilot Randomized Controlled Trial With Economic Evaluation
Anticipated Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Jun 30, 2024
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual care

Usual care group will perform the usual prenatal care indicated by the obstetrician and will receive an educational booklet.

Active Comparator: Pilates

Pilates group will perform the usual prenatal care indicated by the obstetrician and will receive an educational booklet. Additionally, this group will receive an exercise program based on Pilates, twice a week, individually, throughout the gestational period.

Other: Pilates exercises
Sessions will last 60 minutes: five minutes for warming up, 50 minutes for the practice of Pilates exercises, and five minutes for relaxing with the Swiss ball. The exercise protocol will be divided into three gestational phases, covering the entire gestational period, with different and specific objectives for each phase. In all phases, the exercises will be classified into three levels of difficulty: basic, intermediate, and advanced, according to the evolution of each pregnant woman throughout the practice of Pilates. Modifications will be allowed to facilitate or hinder the execution of the movement. The exercises will be performed in one or two sets of seven to 10 repetitions. The number of series, repetitions and exercises and interval time between them, as well as the level of difficulty of the exercises, will be gradually adjusted. The intensity of the exercises will vary between light and moderate and will be controlled by the Borg scale.

Outcome Measures

Primary Outcome Measures

  1. Acceptability measured using a 11-point numerical scale (0 = completely dissatisfied with the treatment results; 10 = completely satisfied with the treatment results) [24th gestational week]

    The participant's perception of the treatment result being satisfactory

  2. Acceptability measured using a 11-point numerical scale (0 = completely dissatisfied with the treatment results; 10 = completely satisfied with the treatment results) [36th gestational week]

    The participant's perception of the treatment result being satisfactory

  3. Acceptability measured using a 11-point numerical scale (0 = completely dissatisfied with the treatment results; 10 = completely satisfied with the treatment results) [From 7 to 15 days after delivery]

    The participant's perception of the treatment result being satisfactory

  4. Suitability measured using 2 questions (one about the need of tailored exercises for the gestational needs and the other about the need of some adaptation during the execution of the exercises) [24th gestational week]

    Assesses whether the exercise program is suitable for the target audience or needs some adaptation

  5. Suitability measured using 2 questions (one about the need of tailored exercises for the gestational needs and the other about the need of some adaptation during the execution of the exercises) [36th gestational week]

    Assesses whether the exercise program is suitable for the target audience or needs some adaptation

  6. Suitability measured using 2 questions (one about the need of tailored exercises for the gestational needs and the other about the need of some adaptation during the execution of the exercises) [From 7 to 15 days after delivery]

    Assesses whether the exercise program is suitable for the target audience or needs some adaptation

  7. Viability measured using a form developed for this study and filled by the physical therapist responsible for the treatment [24th gestational week]

    Assesses recruitment, retention, and participation rates, whether participants reached the end of the treatment program and, if not, why they dropped out

  8. Viability measured using a form developed for this study and filled by the physical therapist responsible for the treatment [36th gestational week]

    Assesses recruitment, retention, and participation rates, whether participants reached the end of the treatment program and, if not, why they dropped out

  9. Viability measured using a form developed for this study and filled by the physical therapist responsible for the treatment [From 7 to 15 days after delivery]

    Assesses recruitment, retention, and participation rates, whether participants reached the end of the treatment program and, if not, why they dropped out

  10. Fidelity measured using an exercise checklist (list of all exercises that can be performed including the level of difficulty) [24th gestational week]

    Assesses the level of difficulty of the selected exercises

  11. Fidelity measured using an exercise checklist (list of all exercises that can be performed including the level of difficulty) [36th gestational week]

    Assesses the level of difficulty of the selected exercises

  12. Fidelity measured using an exercise checklist (list of all exercises that can be performed including the level of difficulty) [From 7 to 15 days after delivery]

    Assesses the level of difficulty of the selected exercises

Secondary Outcome Measures

  1. Occurrence of musculoskeletal complaint [24th gestational week, 36th gestational week, and from seven to 15 days after delivery]

  2. Number of days from randomization on which the musculoskeletal complaint occurred [24th gestational week, 36th gestational week, and from seven to 15 days after delivery]

  3. Delivery mode (normal or caesarean section) [From 7 to 15 days after delivery]

  4. Apgar score (0 to 10) [From 7 to 15 days after delivery]

    Reported at 1 minute and 5 minutes after birth, and at 5-minute intervals thereafter until 20 minutes for infants with a score less than 7

  5. Baby's birth weight [From 7 to 15 days after delivery]

  6. Kinesiophobia measured using the Tampa Scale of Kinesiophobia in the occurrence of musculoskeletal complaint [24th gestational week, 36th gestational week, and from 7 to 15 days after delivery]

    The total score ranges from 17 to 68 points, and the higher the score, the greater the degree of kinesiophobia.

  7. Disability measured using the Patient Specific Functional Scale in the occurrence of musculoskeletal complaint [24th gestational week, 36th gestational week, and from 7 to 15 days after delivery]

    11-point numerical scale (0 = unable to perform the activity; 10 = able to perform the activity at the same level as before the injury or problem)

  8. Pain measured using the Pain Numerical Rating Scale in the occurrence of musculoskeletal complaint [24th gestational week, 36th gestational week, and from 7 to 15 days after delivery]

    11-point numerical scale (0 = no pain; 10 = the worst possible pain)

  9. Costs (healthcare costs, patient and family costs, and lost productivity costs) measured using a questionnaire specially developed for this study [Baseline, 24th gestational week, 36th gestational week, and from 7 to 15 days after delivery]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • pregnant women of usual risk in the 12th gestational week (gestational age determined by the date of the last menstruation or by the ultrasound examination)

  • with medical clearance to practice physical activity

Exclusion Criteria:
  • practice of other physical activity during pregnancy

  • any medical contraindications, such as diabetes and hypertension

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Universidade Cidade de Sao Paulo

Investigators

  • Principal Investigator: Cristina MN Cabral, PhD, Universidade Cidade de São Paulo

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Cristina Maria Nunes Cabral, Professor, Universidade Cidade de Sao Paulo
ClinicalTrials.gov Identifier:
NCT05904925
Other Study ID Numbers:
  • 59486822.3.0000.8084
First Posted:
Jun 15, 2023
Last Update Posted:
Jun 15, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Cristina Maria Nunes Cabral, Professor, Universidade Cidade de Sao Paulo

Study Results

No Results Posted as of Jun 15, 2023